NEUROONE MEDICAL TECHNOLOGIES CORPORATION - COMMON

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

01 May 2025 08:55:00 By Nasdaq GlobeNewswire

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

23 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® Issues Letter to Shareholders

16 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® OneRF® Technology Success Story Featured on Fox News

14 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

04 Apr 2025 07:30:00 By Nasdaq GlobeNewswire

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

03 Apr 2025 15:05:00 By Nasdaq GlobeNewswire

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update

18 Mar 2025 12:12:00 By Nasdaq GlobeNewswire

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace

18 Mar 2025 08:00:01 By Nasdaq GlobeNewswire

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

11 Mar 2025 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

05 Mar 2025 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

12 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

05 Feb 2025 10:00:00 By Nasdaq GlobeNewswire

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

04 Feb 2025 09:56:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

10 Jan 2025 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024

06 Jan 2025 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

03 Jan 2025 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

17 Dec 2024 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time

04 Dec 2024 07:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

31 Oct 2024 15:01:00 By Nasdaq GlobeNewswire

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

24 Oct 2024 08:00:00 By Nasdaq GlobeNewswire